Company profile for Citius Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of important new drug products for growing markets. Citius is currently advancing three proprietary product candidates: Mino-Lok®, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of ca...
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of important new drug products for growing markets. Citius is currently advancing three proprietary product candidates: Mino-Lok®, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of care. Citius is committed to developing therapies for unmet medical needs with cost-effective products in high growth categories with low developmental risk.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11 Commerce Dr, 1st Floor, Cranford, New Jersey 07016
Telephone
Telephone
908.967.6677
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/citius-oncology-announces-us-commercial-launch-of-lymphir-a-novel-cancer-immunotherapy-for-cutaneous-t-cell-lymphoma-ctcl-302627320.html

PR NEWSWIRE
01 Dec 2025

https://www.prnewswire.com/news-releases/citius-oncology-to-exhibit-at-the-67th-american-society-of-hematology-ash-annual-meeting-302625063.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/citius-oncology-to-advance-commercial-launch-of-lymphir-with-verix-ai-integration-302622336.html

PR NEWSWIRE BIO
21 Nov 2025

https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-the-closing-of-registered-direct-offering-of-6-0-million-priced-at-the-market-under-nasdaq-rules-302590470.html

PR NEWSWIRE
22 Oct 2025

https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-a-registered-direct-offering-of-6-0-million-priced-at-the-market-under-nasdaq-rules-302590079.html

PR NEWSWIRE
21 Oct 2025

https://www.prnewswire.com/news-releases/citius-pharmaceuticals-and-citius-oncology-to-participate-in-upcoming-october-2025-conferences-302586084.html

PR NEWSWIRE
17 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty